Bees' Enzyme-Based Covid-19 Treatment Takes Flight
Researchers at a Galway-based biotechnology company, Cellnutrition Health, in collaboration with National University of Ireland (NUI) Galway and Trinity College Dublin, are working on a novel treatment for Covid-19 using a bee enzyme called lysozyme. This enzyme, produced by honeybees to protect their colonies, is being combined with marine plasma in an effort to create a solution that could prevent infection and treat those already infected. The team believes that the treatment, named Beemar, has the potential to work as both a natural vaccine and immunotherapy, effective against not only Covid-19, but also other viruses, bacteria, fungi, and parasites.
Key Takeaways:
- Cellnutrition Health is testing the efficacy of the bees' enzyme lysozyme, combined with marine plasma, as a potential treatment for Covid-19.
- The company plans to work with NUI Galway and Trinity College Dublin on trials, with the goal of creating a treatment that can prevent infection and treat those already infected.
- The bees' enzyme lysozyme is capable of breaking down foreign bodies, making it a potential natural remedy for fighting infections.
- Marine plasma, which contains 78 trace elements and minerals, is being used in conjunction with the lysozyme to enhance its effectiveness.
- The treatment, named Beemar, relies on both adaptive and innate immunity to provide protection against the virus and its variants.
- The company believes that Beemar could be used in five different ways, including eyedrops, nasal spray, oral dose, skin patch, and injected material.
- The treatment is still in the early stages of development, with several years needed to reach fruition.
- The use of natural materials presents less of a challenge in trials and submissions to regulators.
Statistics:
- 78 trace elements and minerals are present in marine plasma.
- The company is working on a partnership with NUI Galway and Trinity College Dublin to develop the treatment.
- The treatment is expected to take several years to reach fruition.
- 21 countries are involved in the Vaccelerate clinical network, a new EU clinical network aimed at accelerating the trials of Covid-19 vaccines.
Sources:
- Siggins, L. (2022). Enzyme produced by honeybees to protect colonies being tested against Covid-19. The Irish Times.
- Irish Times. (2022). Expert-in-residence programme for entrepreneurs and academics opens.
- Cellnutrition Health. (2022). Beemar: A new treatment for Covid-19.